Efficacy of Therapeutic Plasma Exchange Alone or in Combination with Ruxolitinib for the Treatment of Penn Class 3 and 4 Cytokine Release Syndrome Complicating COVID-19

Autor:	Robert A. Brevetta, Sergio Arce, Antine E. Stenbit, Julie C. Martin, Wesley M. Smith, W Larry Gluck, W Jeffery Edenfield, Sean P. Callahan, Anna V. Blenda
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Ruxolitinib Coronavirus disease 2019 (COVID-19) business.industry medicine.disease Clinical trial Cytokine release syndrome Respiratory failure Internal medicine Medicine Therapeutic plasma exchange business medicine.drug
Zdroj:	Journal of Cellular Immunology. 3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9a2f45a2ba61ace352f18f94812b789c https://doi.org/10.33696/immunology.3.100 Zobrazit plný text záznamu